Free data on 57M+ companies

Home > England & Wales Companies > SERA LABORATORIES INTERNATIONAL LIMITED

Company Information for

SERA LABORATORIES INTERNATIONAL LIMITED

C/O OGIER GLOBAL (UK) LIMITED, 4TH FLOOR, 3 ST HELEN'S PLACE, LONDON, EC3A 6AB,

Company Registration Number

03572986

Private Limited Company

Active

Company Overview

About Sera Laboratories International Ltd

SERA LABORATORIES INTERNATIONAL LIMITED was founded on 1998-06-01 and has its registered office in London. The organisation's status is listed as "Active". Sera Laboratories International Limited is a Private Limited Company registered in UNITED KINGDOM with Companies House and the accounts submission requirement is categorised as GROUP

Group companies must submit full accounts if any company is a PLC (Public Limited Company)
Financial services firms: authorised insurance company, a banking company, an e-money issuer, a MiFID investment firm or a UCITS management company must submit full accounts even if they qualify as small
The combined turnover of the group must be < £6.5M, balance sheet <£3.26M and employ less than 50 people to not submit full accounts

Key Data

Legal Registered Office
Company Name
SERA LABORATORIES INTERNATIONAL LIMITED

C/O OGIER GLOBAL (UK) LIMITED 4TH FLOOR, 3 ST HELEN'S PLACE LONDON EC3A 6AB Other companies in E1W

Filing Information

Company Number		03572986
Company ID Number		03572986
Date formed		1998-06-01
Country		UNITED KINGDOM
Origin Country		United Kingdom
Type		Private Limited Company
CompanyStatus		Active
Lastest accounts		31/12/2023
Account next due		30/09/2025
Latest return		15/06/2016
Return next due		13/07/2017
Type of accounts		GROUP
VAT Number /Sales tax ID		GB702816456

Last Datalog update:	2025-03-05 05:30:17
Primary Source:	Companies House

There are multiple companies registered at this address, the registered address may be the accountant's offices for SERA LABORATORIES INTERNATIONAL LIMITED

Company directors
Liabilities
Patents
Trademarks
Intangible assets
Goods imported
Filing history
Outgoings

Is this data useful to you?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of SERA LABORATORIES INTERNATIONAL LIMITED

Current Directors

Officer	Role	Date Appointed
ADAM SILVERS	Company Secretary	2016-11-16
DONALD ALLAN DEIESO	Director	2016-06-13
JEFFREY MITCHELL GATZ	Director	2014-07-01
STEPHEN MCLEAN	Director	2016-06-13
WILLIAM TEMPONE	Director	2016-06-13
MIGUEL BERNARD TOBIN	Director	2016-06-13

Previous Officers

Officer	Role	Date Appointed	Date Resigned
ALAN LEFKOWITZ	Company Secretary	2016-06-13	2016-11-16
ROBERT CHARLES DUNN	Director	2014-07-01	2016-06-13
HARRY HOLIDAY III	Director	2014-07-01	2016-06-13
JENNIFER ANN MURRAY	Company Secretary	2014-06-20	2014-07-01
JENNIFER ANN MURRAY	Director	1998-06-01	2014-07-01
MELANIE MURRAY	Company Secretary	2000-02-25	2014-06-20
MELANIE MURRAY	Director	2000-02-25	2014-06-20
RASIK VADGAMA	Director	2003-05-01	2004-07-01
RASIK VADGAMA	Company Secretary	1998-12-01	2000-02-29
RASIK VADGAMA	Director	1998-12-01	2000-02-29
DEREK BARNETT	Company Secretary	1998-06-01	1998-12-01
DEREK BARNETT	Director	1998-06-01	1998-12-01
HALLMARK SECRETARIES LIMITED	Nominated Secretary	1998-06-01	1998-06-01
HALLMARK REGISTRARS LIMITED	Nominated Director	1998-06-01	1998-06-01

Related Directorships

Officer	Related Company	Role	Date Appointed	Role Status	Incorporation date	Company Status
WILLIAM TEMPONE	PRECISION FOR MEDICINE (UK LABS) LIMITED	Director	2017-08-09	CURRENT	2012-06-01	Active

More director information

Corporation Filing History

Companies House Filing History

This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

Date	Document Type	Document Description
2024-10-31		Appointment of Ogier Global (Uk) Limited as company secretary on 2024-10-25
2024-10-30		REGISTERED OFFICE CHANGED ON 30/10/24 FROM Suite 1, 7th Floor 50 Broadway London SW1H 0BL United Kingdom
2024-06-17		CONFIRMATION STATEMENT MADE ON 15/06/24, WITH NO UPDATES
2024-02-29		GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/22
2023-11-29		Director's details changed for Mr Miguel Bernard Tobin on 2023-11-29
2023-11-29		Director's details changed for Mr Richard John Haigh on 2023-11-29
2023-07-21		APPOINTMENT TERMINATED, DIRECTOR WILLIAM TEMPONE
2023-07-21		DIRECTOR APPOINTED MS. LAURIE FULLER
2023-07-21		DIRECTOR APPOINTED ANDREA ROMOLI
2023-06-21		CONFIRMATION STATEMENT MADE ON 15/06/23, WITH UPDATES
2023-02-06		GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/21
2023-02-06	AA	GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/21
2022-11-04	SH01	15/09/22 STATEMENT OF CAPITAL GBP 146
2022-10-19	CH01	Director's details changed for Mr Richard John Haigh on 2022-10-19
2022-10-19	AD01	REGISTERED OFFICE CHANGED ON 19/10/22 FROM Suite 1, 3rd Floor 11 - 12 st. James's Square London SW1Y 4LB United Kingdom
2022-10-17	TM01	APPOINTMENT TERMINATED, DIRECTOR JEFFREY MITCHELL GATZ
2022-10-17	AP01	DIRECTOR APPOINTED MR RICHARD JOHN HAIGH
2022-09-29		Termination of appointment of Adam Silvers on 2022-09-29
2022-09-29	TM02	Termination of appointment of Adam Silvers on 2022-09-29
2022-06-15	CS01	CONFIRMATION STATEMENT MADE ON 15/06/22, WITH UPDATES
2022-03-07	PSC08	Notification of a person with significant control statement
2022-03-07	PSC07	CESSATION OF BIOIVT, LLC AS A PERSON OF SIGNIFICANT CONTROL
2022-02-09		Notification of Bioivt, Llc as a person with significant control on 2021-10-01
2022-02-09	PSC02	Notification of Bioivt, Llc as a person with significant control on 2021-10-01
2022-01-31		CESSATION OF TERRENCE M. MULLEN AS A PERSON OF SIGNIFICANT CONTROL
2022-01-31		CESSATION OF TERRENCE M. MULLEN AS A PERSON OF SIGNIFICANT CONTROL
2022-01-31		CESSATION OF JEFFREY B. KOVACH AS A PERSON OF SIGNIFICANT CONTROL
2022-01-31		CESSATION OF JEFFREY B. KOVACH AS A PERSON OF SIGNIFICANT CONTROL
2022-01-31	PSC07	CESSATION OF TERRENCE M. MULLEN AS A PERSON OF SIGNIFICANT CONTROL
2021-12-19		SMALL COMPANY ACCOUNTS MADE UP TO 31/12/20
2021-12-19		SMALL COMPANY ACCOUNTS MADE UP TO 31/12/20
2021-12-19	AA	SMALL COMPANY ACCOUNTS MADE UP TO 31/12/20
2021-11-11	AP01	DIRECTOR APPOINTED PIYUSH LALIT SHUKLA
2021-11-10	AP01	DIRECTOR APPOINTED ADAM FRIEDMAN
2021-11-10	TM01	APPOINTMENT TERMINATED, DIRECTOR DONALD ALLAN DEIESO
2021-06-15	CS01	CONFIRMATION STATEMENT MADE ON 15/06/21, WITH NO UPDATES
2021-04-02	AA	SMALL COMPANY ACCOUNTS MADE UP TO 31/12/19
2020-07-07	CH01	Director's details changed for Miguel Bernard Tobin on 2020-07-07
2020-06-15	CS01	CONFIRMATION STATEMENT MADE ON 15/06/20, WITH UPDATES
2019-10-02	AA	SMALL COMPANY ACCOUNTS MADE UP TO 31/12/18
2019-06-26	CS01	CONFIRMATION STATEMENT MADE ON 15/06/19, WITH NO UPDATES
2019-06-17	CH01	Director's details changed for Donald Allan Deieso on 2019-06-14
2018-11-02	AA	SMALL COMPANY ACCOUNTS MADE UP TO 31/12/17
2018-06-20	CS01	CONFIRMATION STATEMENT MADE ON 15/06/18, WITH NO UPDATES
2018-03-07	AD01	REGISTERED OFFICE CHANGED ON 07/03/18 FROM 209, Tower Bridge Business Centre 46-48 East Smithfield London E1W 1AW
2017-10-11	AA	FULL ACCOUNTS MADE UP TO 31/12/16
2017-06-17	LATEST SOC	17/06/17 STATEMENT OF CAPITAL;GBP 100
2017-06-17	CS01	CONFIRMATION STATEMENT MADE ON 15/06/17, WITH UPDATES
2017-01-03	TM02	Termination of appointment of Alan Lefkowitz on 2016-11-16
2017-01-03	AP03	Appointment of Adam Silvers as company secretary on 2016-11-16
2016-09-22	AA	FULL ACCOUNTS MADE UP TO 31/12/15
2016-06-30	AR01	15/06/16 ANNUAL RETURN FULL LIST
2016-06-29	AP01	DIRECTOR APPOINTED WILLIAM TEMPONE
2016-06-29	AP01	DIRECTOR APPOINTED DONALD DEIESO
2016-06-29	AP01	DIRECTOR APPOINTED STEPHEN MCLEAN
2016-06-29	AP03	Appointment of Alan Lefkowitz as company secretary on 2016-06-13
2016-06-29	TM01	APPOINTMENT TERMINATED, DIRECTOR HARRY HOLIDAY III
2016-06-29	TM01	APPOINTMENT TERMINATED, DIRECTOR ROBERT DUNN III
2016-06-29	AP01	DIRECTOR APPOINTED MIGUEL BERNARD TOBIN
2015-11-15	AA	FULL ACCOUNTS MADE UP TO 31/12/14
2015-08-06	AA01	Previous accounting period shortened from 30/06/15 TO 31/12/14
2015-06-04	LATEST SOC	04/06/15 STATEMENT OF CAPITAL;GBP 100
2015-06-04	AR01	01/06/15 ANNUAL RETURN FULL LIST
2015-04-27	AA	30/06/14 ACCOUNTS TOTAL EXEMPTION SMALL
2015-04-16	AA01	Previous accounting period shortened from 31/12/14 TO 30/06/14
2015-02-04	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MR JEFFREY MITCHELL GATZ / 15/01/2015
2015-02-04	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MR ROBERT CHARLES DUNN III / 15/01/2015
2015-02-04	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MR HARRY HOLIDAY III / 15/01/2015
2015-02-04	AD01	REGISTERED OFFICE CHANGED ON 04/02/2015 FROM 411 TOWER BRIDGE BUSINESS CENTRE 46-48 EAST SMITHFIELD LONDON E1W 1AW ENGLAND
2015-02-04	AA01	PREVEXT FROM 30/06/2014 TO 31/12/2014
2014-10-02	MR04	STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE NO 1
2014-08-19	AD01	REGISTERED OFFICE CHANGED ON 19/08/2014 FROM NORTHSIDE HOUSE MOUNT PLEASANT BARNET HERTFORDSHIRE EN4 9EE
2014-08-04	AP01	DIRECTOR APPOINTED MR HARRY HOLIDAY III
2014-08-04	AP01	DIRECTOR APPOINTED MR JEFFREY MITCHELL GATZ
2014-08-04	AP01	DIRECTOR APPOINTED MR ROBERT CHARLES DUNN III
2014-07-31	TM01	APPOINTMENT TERMINATED, DIRECTOR JENNIFER MURRAY
2014-07-31	TM02	APPOINTMENT TERMINATED, SECRETARY JENNIFER MURRAY
2014-07-29	LATEST SOC	29/07/14 STATEMENT OF CAPITAL;GBP 100
2014-07-29	AR01	01/06/14 FULL LIST
2014-07-29	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MS JENNIFER ANN MURRAY / 01/06/2014
2014-06-23	AP03	SECRETARY APPOINTED MRS JENNIFER ANN MURRAY
2014-06-23	TM01	APPOINTMENT TERMINATED, DIRECTOR MELANIE MURRAY
2014-06-23	TM02	APPOINTMENT TERMINATED, SECRETARY MELANIE MURRAY
2014-04-04	AA	30/06/13 TOTAL EXEMPTION SMALL
2013-07-10	AR01	02/06/13 FULL LIST
2013-06-27	AR01	01/06/13 FULL LIST
2013-04-08	AA	30/06/12 TOTAL EXEMPTION SMALL
2012-06-29	AR01	01/06/12 FULL LIST
2012-04-03	AA	30/06/11 TOTAL EXEMPTION SMALL
2011-07-15	AR01	01/06/11 FULL LIST
2011-04-04	AA	30/06/10 TOTAL EXEMPTION SMALL
2010-06-17	AR01	01/06/10 FULL LIST
2010-06-17	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MELANIE MURRAY / 01/10/2009
2010-03-05	AA	30/06/09 TOTAL EXEMPTION SMALL
2009-07-16	363a	RETURN MADE UP TO 01/06/09; FULL LIST OF MEMBERS
2009-05-05	AA	30/06/08 TOTAL EXEMPTION SMALL
2008-06-11	363a	RETURN MADE UP TO 01/06/08; FULL LIST OF MEMBERS
2008-05-01	AA	30/06/07 TOTAL EXEMPTION SMALL
2007-11-27	395	PARTICULARS OF MORTGAGE/CHARGE
2007-06-25	363a	RETURN MADE UP TO 01/06/07; FULL LIST OF MEMBERS
2007-06-12	AA	TOTAL EXEMPTION SMALL ACCOUNTS MADE UP TO 30/06/06
2006-07-10	363a	RETURN MADE UP TO 01/06/06; FULL LIST OF MEMBERS
2006-04-20	AA	TOTAL EXEMPTION SMALL ACCOUNTS MADE UP TO 30/06/05
2005-07-26	AA	TOTAL EXEMPTION SMALL ACCOUNTS MADE UP TO 30/06/04
2005-06-14	363s	RETURN MADE UP TO 01/06/05; FULL LIST OF MEMBERS
2004-08-16	288b	DIRECTOR RESIGNED
2004-08-03	AA	TOTAL EXEMPTION SMALL ACCOUNTS MADE UP TO 30/06/03
2004-06-17	363s	RETURN MADE UP TO 01/06/04; FULL LIST OF MEMBERS
2003-09-02	AA	TOTAL EXEMPTION SMALL ACCOUNTS MADE UP TO 30/06/02
2003-06-16	363s	RETURN MADE UP TO 01/06/03; FULL LIST OF MEMBERS
2003-06-10	288a	NEW DIRECTOR APPOINTED
2002-08-03	AA	TOTAL EXEMPTION SMALL ACCOUNTS MADE UP TO 30/06/01
2002-06-21	363s	RETURN MADE UP TO 01/06/02; FULL LIST OF MEMBERS
2001-06-21	363s	RETURN MADE UP TO 01/06/01; FULL LIST OF MEMBERS
2001-03-02	AA	ACCOUNTS FOR 'SMALL' CO. MADE UP TO 30/06/00
2000-07-10	363(288)	SECRETARY'S PARTICULARS CHANGED;DIRECTOR'S PARTICULARS CHANGED
2000-07-10	363s	RETURN MADE UP TO 01/06/00; FULL LIST OF MEMBERS
2000-04-05	AA	ACCOUNTS FOR 'SMALL' CO. MADE UP TO 30/06/99
2000-03-28	288b	SECRETARY RESIGNED;DIRECTOR RESIGNED
2000-03-28	288a	NEW SECRETARY APPOINTED;NEW DIRECTOR APPOINTED
1999-11-16	363s	RETURN MADE UP TO 01/06/99; FULL LIST OF MEMBERS
1999-10-20	288a	NEW SECRETARY APPOINTED;NEW DIRECTOR APPOINTED
1999-08-11	288b	SECRETARY RESIGNED;DIRECTOR RESIGNED
1998-06-29	288a	NEW SECRETARY APPOINTED;NEW DIRECTOR APPOINTED
1998-06-17	288b	SECRETARY RESIGNED
1998-06-17	288b	DIRECTOR RESIGNED
1998-06-17	288a	NEW DIRECTOR APPOINTED
1998-06-01	NEWINC	INCORPORATION DOCUMENTS CERTIFICATE OF INCORPORATION STATEMENT OF DIRECTORS & REGISTERED OFFICE DECLARATION OF COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION

Industry Information

SIC/NAIC Codes

46 - Wholesale trade, except of motor vehicles and motorcycles

469 - Non-specialised wholesale trade

46900 - Non-specialised wholesale trade

Licences & Regulatory approval

We could not find any licences issued to SERA LABORATORIES INTERNATIONAL LIMITED or authorisation from an industry specific regulator to operate. These may not be required.

Share this page on Facebook

Risks

Legal Notices

No legal notices or events such as winding-up orders or proposals to strike-off have been issued

Fines / Sanctions

No fines or sanctions have been issued against SERA LABORATORIES INTERNATIONAL LIMITED

Liabilities

Mortgages / Charges

Total # Mortgages/Charges	1
Mortgages/Charges outstanding	0
Mortgages Partially Satisifed	0
Mortgages Satisfied/Paid	1

Details of Mortgagee Charges

Charge Type	Date of Charge	Charge Status	Mortgagee
DEBENTURE	2007-11-27	Satisfied	HSBC BANK PLC

Intangible Assets

Patents

We have not found any records of SERA LABORATORIES INTERNATIONAL LIMITED registering or being granted any patents

Domain Names

SERA LABORATORIES INTERNATIONAL LIMITED owns 1 domain names.

seratrials.co.uk

Trademarks

We have not found any records of SERA LABORATORIES INTERNATIONAL LIMITED registering or being granted any trademarks

Income

Government Income

We have not found government income sources for SERA LABORATORIES INTERNATIONAL LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (46900 - Non-specialised wholesale trade) as SERA LABORATORIES INTERNATIONAL LIMITED are:

WOLSELEY UK LIMITED	£ 1,410,392
MARLBOROUGH HOUSE LIMITED	£ 1,008,448
ASKEWS AND HOLTS LIBRARY SERVICES LTD.	£ 655,476
HOLME DODSWORTH (ROCK SALT) LIMITED	£ 295,226
DS REMCO UK LIMITED	£ 231,815
ELM OFFICE PRODUCTS LTD.	£ 190,975
COMPANY 03856179 LIMITED	£ 179,031
ARDEN WINCH & CO LIMITED	£ 139,586
DATA INTEGRATION LIMITED	£ 138,535
JAMES LISTER & SONS LIMITED	£ 122,689
NOTTINGHAM REHAB LIMITED	£ 42,597,787
ASKEWS AND HOLTS LIBRARY SERVICES LTD.	£ 35,187,645
WOLSELEY UK LIMITED	£ 24,398,807
DS REMCO UK LIMITED	£ 13,146,939
ORIGIN AMENITY SOLUTIONS LIMITED	£ 5,653,950
MISCO UK LIMITED	£ 4,080,855
REXEL UK LIMITED	£ 3,835,804
MARLBOROUGH HOUSE LIMITED	£ 3,835,068
TPG DISABLEAIDS LIMITED	£ 3,703,832
UNIVAR SOLUTIONS UK LIMITED	£ 3,662,089
NOTTINGHAM REHAB LIMITED	£ 42,597,787
ASKEWS AND HOLTS LIBRARY SERVICES LTD.	£ 35,187,645
WOLSELEY UK LIMITED	£ 24,398,807
DS REMCO UK LIMITED	£ 13,146,939
ORIGIN AMENITY SOLUTIONS LIMITED	£ 5,653,950
MISCO UK LIMITED	£ 4,080,855
REXEL UK LIMITED	£ 3,835,804
MARLBOROUGH HOUSE LIMITED	£ 3,835,068
TPG DISABLEAIDS LIMITED	£ 3,703,832
UNIVAR SOLUTIONS UK LIMITED	£ 3,662,089
NOTTINGHAM REHAB LIMITED	£ 42,597,787
ASKEWS AND HOLTS LIBRARY SERVICES LTD.	£ 35,187,645
WOLSELEY UK LIMITED	£ 24,398,807
DS REMCO UK LIMITED	£ 13,146,939
ORIGIN AMENITY SOLUTIONS LIMITED	£ 5,653,950
MISCO UK LIMITED	£ 4,080,855
REXEL UK LIMITED	£ 3,835,804
MARLBOROUGH HOUSE LIMITED	£ 3,835,068
TPG DISABLEAIDS LIMITED	£ 3,703,832
UNIVAR SOLUTIONS UK LIMITED	£ 3,662,089

Outgoings

Business Rates/Property Tax

No properties were found where SERA LABORATORIES INTERNATIONAL LIMITED is liable for the business rates / property tax. This could be for a number of reasons.

The council hasnt published the data
We havent found or been able to process the councils data
The company is part of a group of companies and another company in the group is liable for business rates
The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.

Import/Export of Goods

Goods imported/exported by SERA LABORATORIES INTERNATIONAL LIMITED

Date	Import Code	Imported Goods classification description
2015-07-01	30021091	Haemoglobin, blood globulins and serum globulins
2015-07-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2015-07-01	30029010	Human blood
2015-07-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2015-06-01	30012010	Extracts of glands or other organs or of their secretions, of human origin, for organo-therapeutic uses
2015-06-01	30021010	Antisera
2015-06-01	30021091	Haemoglobin, blood globulins and serum globulins
2015-06-01	30029010	Human blood
2015-06-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2015-06-01	30029050	Cultures of micro-organisms (excl. yeasts)
2015-05-01	30012090	Extracts of glands or other organs or of their secretions, of animals, for organo-therapeutic uses
2015-05-01	30021010	Antisera
2015-05-01	30021091	Haemoglobin, blood globulins and serum globulins
2015-05-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2015-05-01	30029010	Human blood
2015-05-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2015-04-01	29411000	Penicillins and their derivatives with a penicillanic acid structure; salts thereof
2015-04-01	30021010	Antisera
2015-04-01	30021091	Haemoglobin, blood globulins and serum globulins
2015-04-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2015-04-01	30029010	Human blood
2015-04-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2015-03-01	30021010	Antisera
2015-03-01	30021091	Haemoglobin, blood globulins and serum globulins
2015-03-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2015-03-01	30029010	Human blood
2015-03-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2015-02-01	30019020	Dried glands and other organs for organo-therapeutic uses, whether or not powdered, and other substances of human origin prepared for therapeutic or prophylactic uses, n.e.s.
2015-02-01	30021010	Antisera
2015-02-01	30021091	Haemoglobin, blood globulins and serum globulins
2015-02-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2015-02-01	30029010	Human blood
2015-02-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2015-01-01	30021010	Antisera
2015-01-01	30021091	Haemoglobin, blood globulins and serum globulins
2015-01-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2015-01-01	30029010	Human blood
2015-01-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2014-12-01	30021010	Antisera
2014-12-01	30021091	Haemoglobin, blood globulins and serum globulins
2014-12-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2014-12-01	30029010	Human blood
2014-12-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2014-11-01	30012090	Extracts of glands or other organs or of their secretions, of animals, for organo-therapeutic uses
2014-11-01	30021091	Haemoglobin, blood globulins and serum globulins
2014-11-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2014-11-01	30029010	Human blood
2014-10-01	30021010	Antisera
2014-10-01	30021091	Haemoglobin, blood globulins and serum globulins
2014-10-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2014-10-01	30029010	Human blood
2014-10-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2014-09-01	30021091	Haemoglobin, blood globulins and serum globulins
2014-09-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2014-09-01	30029010	Human blood
2014-09-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2014-08-01	30021091	Haemoglobin, blood globulins and serum globulins
2014-08-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2014-08-01	30029010	Human blood
2014-08-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2014-06-01	30021010	Antisera
2014-06-01	30021091	Haemoglobin, blood globulins and serum globulins
2014-06-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2014-06-01	30029010	Human blood
2014-04-01	30021010	Antisera
2014-04-01	30021091	Haemoglobin, blood globulins and serum globulins
2014-04-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2014-04-01	30029010	Human blood
2014-03-01	30021010	Antisera
2014-03-01	30021091	Haemoglobin, blood globulins and serum globulins
2014-03-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2014-03-01	30029010	Human blood
2014-03-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2014-02-01	30021010	Antisera
2014-02-01	30029010	Human blood
2014-01-01	30021010	Antisera
2014-01-01	30029010	Human blood
2013-12-01	30021010	Antisera
2013-12-01	30021091	Haemoglobin, blood globulins and serum globulins
2013-12-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2013-12-01	30029010	Human blood
2013-11-01	30021010	Antisera
2013-11-01	30021091	Haemoglobin, blood globulins and serum globulins
2013-11-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2013-11-01	30029010	Human blood
2013-10-01	30021010	Antisera
2013-10-01	30029010	Human blood
2013-10-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2013-09-01	30021010	Antisera
2013-09-01	30021091	Haemoglobin, blood globulins and serum globulins
2013-09-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2013-09-01	30029010	Human blood
2013-09-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2013-08-01	30021091	Haemoglobin, blood globulins and serum globulins
2013-08-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2013-08-01	30029010	Human blood
2013-08-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2013-07-01	30021010	Antisera
2013-07-01	30021091	Haemoglobin, blood globulins and serum globulins
2013-07-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2013-07-01	30029010	Human blood
2013-07-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2013-06-01	30021010	Antisera
2013-06-01	30021091	Haemoglobin, blood globulins and serum globulins
2013-06-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2013-06-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2013-05-01	30021091	Haemoglobin, blood globulins and serum globulins
2013-05-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2013-05-01	30029010	Human blood
2013-05-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2013-04-01	30021010	Antisera
2013-04-01	30021091	Haemoglobin, blood globulins and serum globulins
2013-04-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2013-04-01	30029010	Human blood
2013-03-01	30021010	Antisera
2013-03-01	30021091	Haemoglobin, blood globulins and serum globulins
2013-03-01	30029010	Human blood
2013-02-01	30021091	Haemoglobin, blood globulins and serum globulins
2013-02-01	30021098	Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2013-01-01	30021010	Antisera
2013-01-01	30021091	Haemoglobin, blood globulins and serum globulins
2013-01-01	30029010	Human blood
2013-01-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2013-01-01	30029090	Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)
2013-01-01	83099090	Stoppers, caps and lids, incl. screw caps and pouring stoppers, capsules for bottles, threaded bungs, bung covers, seals and other packing accessories, of base metal (excl. crown corks, capsules of lead and capsules of aluminium of a diameter > 21 mm)
2012-12-01	30021010	Antisera
2012-12-01	30021095
2012-12-01	30021099
2012-11-01	30021091	Haemoglobin, blood globulins and serum globulins
2012-11-01	30021095
2012-11-01	30021099
2012-11-01	30029010	Human blood
2012-10-01	30021010	Antisera
2012-10-01	30021095
2012-10-01	30021099
2012-10-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2012-10-01	35040090	Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed (excl. concentrated milk proteins with a protein content > 85 % by weight, calculated on the dry matter
2012-09-01	30021010	Antisera
2012-09-01	30021095
2012-09-01	30021099
2012-08-01	30021010	Antisera
2012-08-01	30021095
2012-08-01	30021099
2012-08-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2012-07-01	30021010	Antisera
2012-07-01	30021091	Haemoglobin, blood globulins and serum globulins
2012-07-01	30021095
2012-07-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2012-06-01	29411000	Penicillins and their derivatives with a penicillanic acid structure; salts thereof
2012-06-01	30021010	Antisera
2012-06-01	30021091	Haemoglobin, blood globulins and serum globulins
2012-06-01	30021095
2012-06-01	30021099
2012-05-01	29411000	Penicillins and their derivatives with a penicillanic acid structure; salts thereof
2012-05-01	30021010	Antisera
2012-05-01	30021095
2012-05-01	30021099
2012-05-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2012-04-01	30021010	Antisera
2012-04-01	30021095
2012-04-01	30021099
2012-04-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2012-03-01	29419000	Antibiotics (excl. penicillins and their derivatives with a penicillanic acid structure, salts thereof, streptomycins, tetracyclines, chloramphenicol and erythromycin, their derivatives and salts thereof)
2012-03-01	30021010	Antisera
2012-03-01	30021095
2012-03-01	30021099
2012-03-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2012-02-01	30021010	Antisera
2012-02-01	30021095
2012-02-01	30021099
2012-02-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2012-01-01	30021010	Antisera
2012-01-01	30021095
2012-01-01	30021099
2012-01-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2011-12-01	30021010	Antisera
2011-12-01	30021095
2011-12-01	30021099
2011-12-01	30029010	Human blood
2011-12-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2011-12-01	83099090	Stoppers, caps and lids, incl. screw caps and pouring stoppers, capsules for bottles, threaded bungs, bung covers, seals and other packing accessories, of base metal (excl. crown corks, capsules of lead and capsules of aluminium of a diameter > 21 mm)
2011-11-01	30021010	Antisera
2011-11-01	30021095
2011-11-01	30021099
2011-11-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2011-11-01	30029090	Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)
2011-10-01	30019098	Dried glands and other organs for organo-therapeutic uses, whether or not powdered, and other substances of animal origin prepared for therapeutic or prophylactic uses, n.e.s. (excl. heparin and its salts)
2011-10-01	30021095
2011-10-01	30021099
2011-10-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2011-10-01	35040090	Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed (excl. concentrated milk proteins with a protein content > 85 % by weight, calculated on the dry matter
2011-09-01	30021010	Antisera
2011-09-01	30021095
2011-09-01	30021099
2011-09-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2011-08-01	30021010	Antisera
2011-08-01	30021091	Haemoglobin, blood globulins and serum globulins
2011-08-01	30021095
2011-08-01	30021099
2011-08-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2011-08-01	30029090	Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)
2011-07-01	30021010	Antisera
2011-07-01	30021099
2011-06-01	30021010	Antisera
2011-06-01	30021095
2011-06-01	30021099
2011-06-01	30029010	Human blood
2011-06-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2011-05-01	30021010	Antisera
2011-05-01	30021095
2011-05-01	30021099
2011-05-01	30029090	Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)
2011-04-01	30021010	Antisera
2011-04-01	30021095
2011-04-01	30021099
2011-04-01	83099090	Stoppers, caps and lids, incl. screw caps and pouring stoppers, capsules for bottles, threaded bungs, bung covers, seals and other packing accessories, of base metal (excl. crown corks, capsules of lead and capsules of aluminium of a diameter > 21 mm)
2011-03-01	30021010	Antisera
2011-03-01	30021095
2011-03-01	30021099
2011-03-01	30029090	Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)
2011-02-01	30021010	Antisera
2011-02-01	30021095
2011-02-01	30021099
2011-02-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2011-01-01	30021010	Antisera
2011-01-01	30021095
2011-01-01	30021099
2011-01-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2010-12-01	30021010	Antisera
2010-12-01	30021095
2010-12-01	30021099
2010-12-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2010-12-01	30029090	Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)
2010-11-01	30021010	Antisera
2010-11-01	30021095
2010-11-01	30021099
2010-11-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2010-11-01	35040090	Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed (excl. concentrated milk proteins with a protein content > 85 % by weight, calculated on the dry matter
2010-10-01	30021010	Antisera
2010-10-01	30021095
2010-10-01	30021099
2010-10-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2010-10-01	30029090	Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)
2010-09-01	30021010	Antisera
2010-09-01	30021091	Haemoglobin, blood globulins and serum globulins
2010-09-01	30021095
2010-09-01	30021099
2010-09-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2010-08-01	30021010	Antisera
2010-08-01	30021095
2010-08-01	30021099
2010-08-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2010-07-01	30021010	Antisera
2010-07-01	30021095
2010-07-01	30021099
2010-07-01	30029090	Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)
2010-06-01	30021010	Antisera
2010-06-01	30021095
2010-06-01	30021099
2010-06-01	30022000	Vaccines for human medicine
2010-06-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2010-05-01	30021010	Antisera
2010-05-01	30021095
2010-05-01	30021099
2010-05-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2010-05-01	30029050	Cultures of micro-organisms (excl. yeasts)
2010-05-01	30029090	Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)
2010-04-01	30021010	Antisera
2010-04-01	30021095
2010-04-01	30021099
2010-04-01	30029010	Human blood
2010-04-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2010-04-01	30029090	Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)
2010-03-01	30021010	Antisera
2010-03-01	30021099
2010-03-01	30029010	Human blood
2010-02-01	30021010	Antisera
2010-02-01	30021095
2010-02-01	30021099
2010-02-01	30029010	Human blood
2010-02-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2010-01-01	30021010	Antisera
2010-01-01	30021095
2010-01-01	30021099
2010-01-01	30029010	Human blood
2010-01-01	30029030	Animal blood prepared for therapeutic, prophylactic or diagnostic uses

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

Government Grants / Awards

Technology Strategy Board Awards

The Technology Strategy Board has not awarded SERA LABORATORIES INTERNATIONAL LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR

European Union CORDIS Awards

The European Union has not awarded SERA LABORATORIES INTERNATIONAL LIMITED any grants or awards.

Ownership

We could not find any group structure information

Is this data useful to you?

Need more information?

We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.